Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The immunoproteasome and thymoproteasome: functions, evolution and human disease
Shigeo Murata, Yousuke Takahama, Masanori Kasahara, et al.
Nature Immunology (2018) Vol. 19, Iss. 9, pp. 923-931
Closed Access | Times Cited: 260

Showing 1-25 of 260 citing articles:

Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation
Karthik Dhatchinamoorthy, Jeff D. Colbert, Kenneth L. Rock
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 683
A guide to antigen processing and presentation
Novalia Pishesha, Thibault J. Harmand, Hidde L. Ploegh
Nature reviews. Immunology (2022) Vol. 22, Iss. 12, pp. 751-764
Closed Access | Times Cited: 435
Type I interferon response drives neuroinflammation and synapse loss in Alzheimer disease
Ethan R. Roy, Baiping Wang, Ying‐Wooi Wan, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 4, pp. 1912-1930
Open Access | Times Cited: 394
Immunomodulation by endothelial cells — partnering up with the immune system?
Jacob Amersfoort, Guy Eelen, Peter Carmeliet
Nature reviews. Immunology (2022) Vol. 22, Iss. 9, pp. 576-588
Open Access | Times Cited: 275
Proteasome Inhibitor Drugs
Lloyd D. Fricker
The Annual Review of Pharmacology and Toxicology (2019) Vol. 60, Iss. 1, pp. 457-476
Open Access | Times Cited: 226
Radiation therapy and anti-tumor immunity: exposing immunogenic mutations to the immune system
Claire Lhuillier, Nils-Petter Rudqvist, Olivier Elemento, et al.
Genome Medicine (2019) Vol. 11, Iss. 1
Open Access | Times Cited: 222
Dynamic Regulation of the 26S Proteasome: From Synthesis to Degradation
Richard S. Marshall, Richard D. Vierstra
Frontiers in Molecular Biosciences (2019) Vol. 6
Open Access | Times Cited: 194
Cancer vaccines: Building a bridge over troubled waters
MacLean C. Sellars, Catherine J. Wu, Edward F. Fritsch
Cell (2022) Vol. 185, Iss. 15, pp. 2770-2788
Open Access | Times Cited: 191
The Ubiquitin–Proteasome System in Immune Cells
Gonca Çetin, Sandro Klafack, Maja Studencka‐Turski, et al.
Biomolecules (2021) Vol. 11, Iss. 1, pp. 60-60
Open Access | Times Cited: 118
Protein synthesis, degradation, and energy metabolism in T cell immunity
Julia M. Marchingo, Doreen A. Cantrell
Cellular and Molecular Immunology (2022) Vol. 19, Iss. 3, pp. 303-315
Open Access | Times Cited: 100
Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer
Arvind Ravi, Matthew D. Hellmann, Monica Arniella, et al.
Nature Genetics (2023) Vol. 55, Iss. 5, pp. 807-819
Open Access | Times Cited: 91
Disorders of ubiquitylation: unchained inflammation
David B. Beck, Achim Werner, Daniel L. Kastner, et al.
Nature Reviews Rheumatology (2022) Vol. 18, Iss. 8, pp. 435-447
Open Access | Times Cited: 76
Unraveling UPR-Mediated Intercellular Crosstalk: Implications for Immunotherapy Resistance Mechanisms
Lu Si, Qimin Zhou, Rongjie Zhao, et al.
Cancer Letters (2025), pp. 217613-217613
Closed Access | Times Cited: 2
The ubiquitin–proteasome system in kidney physiology and disease
Catherine Meyer-Schwesinger
Nature Reviews Nephrology (2019) Vol. 15, Iss. 7, pp. 393-411
Closed Access | Times Cited: 119
Characterization of Fully Recombinant Human 20S and 20S-PA200 Proteasome Complexes
Ana Toste Rêgo, da Fonseca
Molecular Cell (2019) Vol. 76, Iss. 1, pp. 138-147.e5
Open Access | Times Cited: 102
Structure, Dynamics and Function of the 26S Proteasome
Youdong Mao
Sub-cellular biochemistry/Subcellular biochemistry (2020), pp. 1-151
Open Access | Times Cited: 95
The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges
Grazia R. Tundo, Diego Sbardella, Anna Maria Santoro, et al.
Pharmacology & Therapeutics (2020) Vol. 213, pp. 107579-107579
Open Access | Times Cited: 87
Major Histocompatibility Complex (MHC) Genes and Disease Resistance in Fish
Takuya Yamaguchi, Johannes M. Dijkstra
Cells (2019) Vol. 8, Iss. 4, pp. 378-378
Open Access | Times Cited: 86
Molecular mechanisms of phenotypic variability in monogenic autoinflammatory diseases
Ivona Aksentijevich, Oskar Schnappauf
Nature Reviews Rheumatology (2021) Vol. 17, Iss. 7, pp. 405-425
Closed Access | Times Cited: 60
Integration of Mass Spectrometry Data for Structural Biology
Hannah M. Britt, Tristan Cragnolini, Konstantinos Thalassinos
Chemical Reviews (2021) Vol. 122, Iss. 8, pp. 7952-7986
Open Access | Times Cited: 59
Role of Proteasomes in Inflammation
Carl Christoph Goetzke, Frédéric Ebstein, Tilmann Kallinich
Journal of Clinical Medicine (2021) Vol. 10, Iss. 8, pp. 1783-1783
Open Access | Times Cited: 56
Functional Differences between Proteasome Subtypes
Joanna Abi Habib, Julie Lesenfants, Nathalie Vigneron, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 421-421
Open Access | Times Cited: 55
Global and tissue-specific aging effects on murine proteomes
Gregory R. Keele, Jigang Zhang, John Szpyt, et al.
Cell Reports (2023) Vol. 42, Iss. 7, pp. 112715-112715
Open Access | Times Cited: 30
Ubiquitin–proteasome system as a target for anticancer treatment—an update
Yeon‐Jung Kim, Yeonjoo Lee, H. Y. Shin, et al.
Archives of Pharmacal Research (2023) Vol. 46, Iss. 7, pp. 573-597
Closed Access | Times Cited: 28
DNA sensing via the cGAS/STING pathway activates the immunoproteasome and adaptive T‐cell immunity
Xinyuan Wang, Huabin Zhang, Yuqin Wang, et al.
The EMBO Journal (2023) Vol. 42, Iss. 8
Open Access | Times Cited: 27
Page 1 - Next Page

Scroll to top